Scribe Therapeutics, Inc. (SCTX)
28.05
-4.95
(-15.00%)
USD |
NASDAQ |
Sep 21, 16:00
28.61
+0.56
(+2.00%)
After-Hours: 20:00
Scribe Therapeutics Debt to Equity Ratio : -0.9726 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9726 |
| Date | Value |
|---|---|
| March 31, 2026 | -1.207 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.978 |
| Cypherpunk Technologies, Inc. | 0.0003 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 57.93M |
| Total Liabilities (Quarterly) | 102.42M |
| Shareholders Equity (Quarterly) | -44.49M |
| Current Ratio | 0.5731 |